Kodiak Sciences Inc (KOD)
3.74
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
3.76
+0.02
(+0.53%)
Pre-Market: 20:00
Kodiak Sciences Enterprise Value: -89.03M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | -89.03M |
| May 15, 2024 | -89.03M |
| May 14, 2024 | -83.77M |
| May 13, 2024 | -84.30M |
| May 10, 2024 | -95.86M |
| May 09, 2024 | -85.87M |
| May 08, 2024 | -84.30M |
| May 07, 2024 | -76.42M |
| May 06, 2024 | -78.52M |
| May 03, 2024 | -87.45M |
| May 02, 2024 | -91.13M |
| May 01, 2024 | -100.06M |
| April 30, 2024 | -116.87M |
| April 29, 2024 | -108.46M |
| April 26, 2024 | -113.19M |
| April 25, 2024 | -118.18M |
| April 24, 2024 | -107.94M |
| April 23, 2024 | -110.57M |
| April 22, 2024 | -105.84M |
| April 19, 2024 | -108.99M |
| April 18, 2024 | -103.21M |
| April 17, 2024 | -96.38M |
| April 16, 2024 | -81.15M |
| April 15, 2024 | -82.20M |
| April 12, 2024 | -53.83M |
| Date | Value |
|---|---|
| April 11, 2024 | -51.20M |
| April 10, 2024 | -50.15M |
| April 09, 2024 | -50.68M |
| April 08, 2024 | -60.13M |
| April 05, 2024 | -69.06M |
| April 04, 2024 | -71.21M |
| April 03, 2024 | -61.23M |
| April 02, 2024 | -58.08M |
| April 01, 2024 | -51.78M |
| March 28, 2024 | -9.312M |
| March 27, 2024 | 105.68M |
| March 26, 2024 | 87.30M |
| March 25, 2024 | 35.85M |
| March 22, 2024 | 42.67M |
| March 21, 2024 | 16.94M |
| March 20, 2024 | 17.99M |
| March 19, 2024 | -4.586M |
| March 18, 2024 | 12.22M |
| March 15, 2024 | 22.19M |
| March 14, 2024 | 9.854M |
| March 13, 2024 | 46.35M |
| March 12, 2024 | 25.87M |
| March 11, 2024 | 24.29M |
| March 08, 2024 | 39.00M |
| March 07, 2024 | 40.57M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-410.14M
Minimum
May 11 2022
7.441B
Maximum
Dec 24 2020
1.580B
Average
420.50M
Median
Jul 09 2019
Enterprise Value Benchmarks
| Avalo Therapeutics Inc | 2.554M |
| Regeneron Pharmaceuticals Inc | 98.12B |
| iBio Inc | 16.17M |
| Dare Bioscience Inc | 33.26M |
| Zevra Therapeutics Inc | 189.50M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -59.52M |
| Total Expenses (Quarterly) | 63.37M |
| EPS Diluted (Quarterly) | -1.13 |
| Earnings Yield | -132.6% |